# Vivos Therapeutics, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Vivos Therapeutics, Inc.). ## Overview Vivos Therapeutics, Inc. develops and commercializes oral appliance-based therapies and related clinical protocols for obstructive sleep apnea and other sleep-disordered breathing conditions. The company works through trained dental and medical providers and also operates sleep and airway medicine centers that support diagnosis, treatment, and patient management in the United States. ## Products & services • FDA-cleared DNA appliance and related oral devices • CARE oral medical devices and adjunctive therapies • Vivos Method clinical protocol and provider training • VIP dentist enrollment, support, and technical services • Sleep disorder diagnostics and treatment center operations - **Oral appliance systems** (45%) — Custom oral devices used in sleep apnea and airway treatment protocols. - **Clinical services and enrollments** (20%) — VIP enrollments, training, and support services for provider networks. - **Sleep center operations** (25%) — Diagnostic, consulting, and treatment services delivered through managed centers. - **Adjunctive therapies and support** (10%) — Additional therapies, technical support, and patient-care services tied to the platform. - FDA-cleared DNA appliance and related oral devices - CARE oral medical devices and adjunctive therapies - Vivos Method clinical protocol and provider training - VIP dentist enrollment, support, and technical services - Sleep disorder diagnostics and treatment center operations ## Customers The company sells to dental practices, sleep medicine providers, and medical professionals who use its appliances and protocols to treat obstructive sleep apnea and related airway conditions. It also serves patients through managed sleep and airway medicine centers, where diagnostics and treatment pathways can be coordinated with provider networks. - **VIP dental practices** (primary) — Independent dentists that enroll to prescribe and support Vivos oral appliance therapy and related services. - **Sleep and airway medicine centers** (primary) — Managed centers that provide diagnostics, consulting, and treatment pathways for sleep-disordered breathing. - **Medical sleep providers** (secondary) — Physicians and advanced practice clinicians who participate in center-based sleep care and referrals. - **Patients with OSA and snoring** (primary) — End users receiving appliance-based therapy, diagnostics, and adjunctive treatment services. - Dental practices enrolled as VIPs for appliance-based treatment - Sleep medicine centers seeking diagnostic and treatment workflows - Physicians, nurse practitioners, and physician assistants in centers - Patients with obstructive sleep apnea and related airway disorders - Medical and dental providers needing training and technical support ## Geography Vivos is primarily a United States business, with product commercialization, provider training, and sleep-center operations centered in the U.S. The company has also referenced international treatment experience and distribution collaborations, including a Middle East-North Africa channel, but those initiatives are not yet a major revenue base. - United States is the core operating and revenue market - Provider training and center operations are concentrated in the U.S. - International patient treatment experience has been referenced worldwide - Middle East-North Africa distribution collaboration is still pre-revenue - Imported components create exposure to trade policy and tariffs ## Strategy The company is shifting from a provider-enrollment model toward owning or partnering with sleep and airway medicine centers that can generate diagnostics, consulting, and appliance revenue together. It is also pursuing acquisitions and strategic alliances to expand patient flow, broaden distribution, and build a more integrated care platform around its oral appliance therapies. - **Build a center-based sleep medicine model** (short-term) — Owning or managing centers can create more direct patient access and additional revenue streams. - **Expand strategic alliances and acquisitions** (medium-term) — Partnerships can increase patient volume and broaden distribution without relying only on VIP recruitment. - **Strengthen clinical validation** (medium-term) — Clinical evidence supports provider adoption, payer acceptance, and regulatory credibility. - Shift from VIP dentist enrollment to center-based care delivery - Use acquisitions and alliances to expand patient volume - Capture diagnostics and consulting revenue alongside appliance sales - Support existing VIP base while reducing new VIP recruitment - Pursue clinical evidence and regulatory support for the platform ## Risks Vivos faces execution risk as it transitions to a new operating model that depends on acquisitions, alliances, and center integration rather than the legacy VIP channel. The business also carries financing, Nasdaq compliance, reimbursement, regulatory, and trade-sourcing risks that can affect its ability to operate, scale, and convert clinical demand into revenue. - **Transition to a new sales and distribution model may fail** [high] — The company is moving away from VIP recruitment toward center-based care, which has limited operating history. - **Acquisition and integration risk** [high] — Integrating sleep centers can be costly and operationally disruptive, affecting patients, staff, and standards. - **Liquidity and financing risk** [critical] — The company has indicated it needs additional capital to fund operations and strategic objectives. - **Nasdaq listing and equity requirement compliance** [high] — Failure to maintain compliance could impair stock liquidity and capital raising ability. - **Regulatory and fee-splitting risk** [high] — Managed medical arrangements must comply with state corporate practice and fee-splitting laws. - **Reimbursement and payer policy risk** [medium] — Coverage decisions and reimbursement rates affect the economics of sleep testing and treatment. - New center-based model is unproven and may not deliver expected benefits - Integration of acquired sleep centers may disrupt operations or patient flow - Financing needs create dilution and going-concern risk - Nasdaq equity-compliance risk could affect liquidity and capital access - Reimbursement and regulatory changes can limit billable services - Imported components expose the company to tariffs and trade policy shifts ## Accounting Revenue recognition depends on whether the company is selling appliances, enrollments, or services, and some obligations are satisfied over time while product sales are recognized on delivery. Investors should also watch contract liabilities, capitalized software development, and estimates tied to allowances, discounts, and acquisition-related accounting as the business model becomes more service-heavy. - **Revenue recognition under ASC 606** — Affects quarterly revenue mix and comparability - **Contract liabilities** — Can shift revenue between periods - **Capitalized software development** — Affects operating expense timing and asset balances - **Acquisition and intangible asset accounting** — Could materially affect balance sheet and earnings - **Going-concern and equity deficit disclosures** — Important for solvency and valuation analysis - Revenue timing differs for appliance sales and enrollment/service revenue - Contract liabilities affect when prepaid services become revenue - Allowance and discount estimates reduce reported net revenue - Capitalized internal-use software affects investing cash flow and assets - Acquisition accounting may create intangible assets and goodwill - Going-concern disclosures and equity deficits affect financial statement interpretation --- *Last updated: 2026-04-29T05:08:34.450071+00:00*